Xiaobin Wu

2019

In 2019, Xiaobin Wu earned a total compensation of $9.1M as General Manager of China and President at BeiGene, Ltd., a 58% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$379,727
Option Awards$3,999,953
Salary$581,957
Stock Awards$3,999,946
Other$165,813
Total$9,127,396

Wu received $4M in option awards, accounting for 44% of the total pay in 2019.

Wu also received $379.7K in non-equity incentive plan, $582K in salary, $4M in stock awards and $165.8K in other compensation.

Rankings

In 2019, Xiaobin Wu's compensation ranked 886th out of 13,971 executives tracked by ExecPay. In other words, Wu earned more than 93.7% of executives.

ClassificationRankingPercentile
All
886
out of 13,971
94th
Division
Manufacturing
308
out of 5,692
95th
Major group
Chemicals And Allied Products
88
out of 2,189
96th
Industry group
Drugs
71
out of 1,875
96th
Industry
Pharmaceutical Preparations
57
out of 1,387
96th
Source: SEC filing on April 28, 2020.

Wu's colleagues

We found four more compensation records of executives who worked with Xiaobin Wu at BeiGene, Ltd. in 2019.

2019

John Oyler

BeiGene, Ltd.

Chief Executive Officer

2019

Howard Liang

BeiGene, Ltd.

Chief Financial Officer

2019

Jane Huang

BeiGene, Ltd.

Chief Medical Officer

2019

Amy Peterson

BeiGene, Ltd.

Chief Medical Officer

News

You may also like